Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase NA 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Lymphoma 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Multiple Myeloma 8Leukemia, Myeloid, Acute 8Hodgkin Disease 8Recurrence 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Lymphocytic, Chronic, B-Cell 6Leukemia 6Burkitt Lymphoma 6Myelodysplastic Syndromes 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Neuroblastoma 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Dendritic Cell Sarcoma, Interdigitating 4Congenital Abnormalities 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Retinoblastoma 3Primary Myelofibrosis 3Myeloproliferative Disorders 3Mycosis Fungoides 3Lymphoma, Extranodal NK-T-Cell 3

Interventions

Dexamethasone 24-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2pomalidomide 1Tacrolimus 1Melphalan 1Lenalidomide 1Hyaluronoglucosaminidase 1Calcium Dobesilate 1Bortezomib 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Amyloidosis × Melphalan × Clear all
NCT00890552 2017-03-22

A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis

Stanford University

Phase NA Completed
25 enrolled 12 charts
Other hematologic neoplasmPlasma cell

Amyloidosis, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡